Spencer Pharmaceutical Inc.
SPPH
$0.00
$0.000.00%
OTC PK
| 12/31/2010 | 06/30/2010 | 03/31/2010 | |||
|---|---|---|---|---|---|
| Revenue | -- | -- | -- | ||
| Total Other Revenue | -- | -- | -- | ||
| Total Revenue | -- | -- | -- | ||
| Cost of Revenue | -- | -- | -- | ||
| Gross Profit | -- | -- | -- | ||
| SG&A Expenses | 754.50K | 56.40K | 56.40K | ||
| Depreciation & Amortization | -- | -- | -- | ||
| Other Operating Expenses | -- | -- | -- | ||
| Total Operating Expenses | 754.50K | 56.40K | 56.40K | ||
| Operating Income | -754.50K | -56.40K | -56.40K | ||
| Income Before Tax | -754.50K | -56.40K | -56.40K | ||
| Income Tax Expenses | -- | -- | -- | ||
| Earnings from Continuing Operations | -754.50K | -56.40K | -56.40K | ||
| Earnings from Discontinued Operations | -- | -- | -- | ||
| Extraordinary Item & Accounting Change | -- | -- | -- | ||
| Minority Interest in Earnings | -- | -- | -- | ||
| Net Income | -754.50K | -56.40K | -56.40K | ||
| EBIT | -754.50K | -56.40K | -56.40K | ||
| EBITDA | -- | -- | -- | ||
| EPS Basic | 0.00 | 0.00 | 0.00 | ||
| Normalized Basic EPS | 0.00 | 0.00 | 0.00 | ||
| EPS Diluted | 0.00 | 0.00 | 0.00 | ||
| Normalized Diluted EPS | 0.00 | 0.00 | 0.00 | ||
| Average Basic Shares Outstanding | 271.27M | 258.43M | 258.43M | ||
| Average Diluted Shares Outstanding | 271.27M | 258.43M | 258.43M | ||
| Dividend Per Share | -- | -- | -- | ||
| Payout Ratio | -- | -- | -- | ||